PCSK9 and colorectal carcinoma: To assess horizontal pleiotropy, the results from MR‐Egger suggested the presence of pleiotropy for PCSK9‐mediated LDL in EC (p = 0.02), CRC (p < 0.01), and pancreatic head cancer (p = 0.01) (Tables S4 and S5).